The pericyte: Cellular regulator of microvascular blood flow
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abe, 2004, Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats, Circ. Res., 94, 385, 10.1161/01.RES.0000111804.34509.94
Akgoren, 1994, Importance of nitric oxide for local increases of blood flow in rat cerebellar cortex during electrical stimulation, Proc. Natl. Acad. Sci. U. S. A., 91, 5903, 10.1073/pnas.91.13.5903
Amano, 2001, LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505, Biochem. J., 354, 149, 10.1042/bj3540149
Annes, 2004, Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1, J. Cell Biol., 165, 723, 10.1083/jcb.200312172
Antonelli-Orlidge, 1989, An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes, Proc. Natl. Acad. Sci. U. S. A., 86, 4544, 10.1073/pnas.86.12.4544
Arber, 1998, Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase, Nature, 393, 805, 10.1038/31729
Armulik, 2005, Endothelial/pericyte interactions, Circ. Res., 97, 512, 10.1161/01.RES.0000182903.16652.d7
Asano, 1987, Mechanism of action of a novel antivasospasm drug, HA1077, J. Pharmacol. Exp. Ther., 241, 1033
Bagley, 2006, Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapy, Microvasc. Res., 71, 163, 10.1016/j.mvr.2006.03.002
Baluk, 2003, Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors, Am. J. Pathol., 163, 1801, 10.1016/S0002-9440(10)63540-7
Bamburg, 1999, Proteins of the ADF/cofilin family: essential regulators of actin dynamics, Annu. Rev. Cell Dev. Biol., 15, 185, 10.1146/annurev.cellbio.15.1.185
Beck, 1997, Vascular development: cellular and molecular regulation, FASEB J., 11, 365, 10.1096/fasebj.11.5.9141503
Benjamin, 1998, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF, Development, 125, 1591, 10.1242/dev.125.9.1591
Benjamin, 1999, Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal, J. Clin. Invest., 103, 159, 10.1172/JCI5028
Berg, 1997, Direct coupling between blood flow and metabolism at the capillary level in striated muscle, Am. J. Physiol., 272, H2693
Bergers, 2005, The role of pericytes in blood-vessel formation and maintenance, Neuro-Oncol., 7, 452, 10.1215/S1152851705000232
Bergers, 2003, Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors, J. Clin. Invest., 111, 1287, 10.1172/JCI200317929
Bertolino, 2005, Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders, Chest, 128, 585S, 10.1378/chest.128.6_suppl.585S
Betsholtz, 2005, Role of pericytes in vascular morphogenesis, EXS, 115
Birukova, 2005, Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction, J. Cell. Physiol., 204, 934, 10.1002/jcp.20359
Bjarnegard, 2004, Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities, Development, 131, 1847, 10.1242/dev.01080
Brown, 1999, MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells, J. Biol. Chem., 274, 8797, 10.1074/jbc.274.13.8797
Bryan, 2007, What tangled webs they weave: Rho-GTPase control of angiogenesis, Cell. Mol. Life Sci., 64, 2053, 10.1007/s00018-007-7008-z
Budzyn, 2005, Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension, J. Pharmacol. Exp. Ther., 313, 1248, 10.1124/jpet.104.082784
Cai, 2008, The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy, Invest. Ophthalmol. Vis. Sci., 49, 2163, 10.1167/iovs.07-1206
Carter, 2002, Acute and chronic NOS inhibition enhances alpha(2)- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta, Am. J. Physiol, Heart Circ. Physiol., 283, H1361, 10.1152/ajpheart.01101.2001
Carvajal, 2000, Molecular mechanism of cGMP-mediated smooth muscle relaxation, J. Cell. Physiol., 184, 409, 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K
Castaneda, 2001, Hypoxic pulmonary vasoconstriction increases during endotoxemia in the perfused rat lung, J. Trauma, 50, 882, 10.1097/00005373-200105000-00018
Chitaley, 2002, Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling, Hypertension, 39, 438, 10.1161/hy02t2.102960
Clements, 2005, RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability, Am. J. Physiol., Lung Cell. Mol. Physiol., 288, L294, 10.1152/ajplung.00213.2004
Cogan, 1961, Retinal vascular patterns. IV. Diabetic retinopathy, Arch. Ophthalmol., 66, 366, 10.1001/archopht.1961.00960010368014
Cogolludo, 2007, Mechanisms controlling vascular tone in pulmonary arterial hypertension: implications for vasodilator therapy, Pharmacology, 79, 65, 10.1159/000097754
Cohen, 2002, Muscle contraction under capillaries in hamster muscle induces arteriolar dilatation via K(ATP) channels and nitric oxide, J. Physiol., 539, 547, 10.1113/jphysiol.2001.013388
Cohen, 2000, Remote arteriolar dilations in response to muscle contraction under capillaries, Am. J. Physiol, Heart Circ. Physiol., 278, H1916, 10.1152/ajpheart.2000.278.6.H1916
Crocker, 1970, Role of the pericyte in wound healing. An ultrastructural study, Exp. Mol. Pathol., 13, 51, 10.1016/0014-4800(70)90084-5
D'Amore, 1998, Growth control in the retinal microvasculature, Prog. Retin. Res., 7, 233, 10.1016/0278-4327(88)90010-7
Darland, 1999, Blood vessel maturation: vascular development comes of age, J. Clin. Invest., 103, 157, 10.1172/JCI6127
Darland, 2001, Cell–cell interactions in vascular development, Curr. Top. Dev. Biol., 52, 107, 10.1016/S0070-2153(01)52010-4
Darland, 2001, TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells, Angiogenesis, 4, 11, 10.1023/A:1016611824696
Darland, 2003, Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival, Dev. Biol., 264, 275, 10.1016/j.ydbio.2003.08.015
Denekamp, 1982, Endothelial-cell proliferation in experimental tumours, Br. J. Cancer, 46, 711, 10.1038/bjc.1982.263
Didion, 2005, Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes, Stroke, 36, 342, 10.1161/01.STR.0000152952.42730.92
Dinbergs, 1996, Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions, J. Biol. Chem., 271, 29822, 10.1074/jbc.271.47.29822
Ding, 2004, Endothelial–mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation, Stem Cells Dev., 13, 509, 10.1089/scd.2004.13.509
El-Bizri, 2008, SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis, Development, 135, 2981, 10.1242/dev.017863
Engerman, 1967, Cell turnover of capillaries, Lab. Invest., 17, 738
Erber, 2004, Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms, FASEB J., 18, 338, 10.1096/fj.03-0271fje
Ertel, 1995, Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release, Am. J. Physiol., 269, R160
Fagan, 2004, Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase, Am. J. Physiol., Lung Cell. Mol. Physiol., 287, L656, 10.1152/ajplung.00090.2003
Faraci, 1998, Regulation of the cerebral circulation: role of endothelium and potassium channels, Physiol. Rev., 78, 53, 10.1152/physrev.1998.78.1.53
Faraci, 2006, Cerebral vascular effects of angiotensin II: new insights from genetic models, J. Cereb. Blood Flow Metab., 26, 449, 10.1038/sj.jcbfm.9600204
Farhadi, 2005, Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas, J. Neurosurg., 102, 363, 10.3171/jns.2005.102.2.0363
Flanders, 1989, Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes, J. Cell Biol., 108, 653, 10.1083/jcb.108.2.653
Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108
Folkman, 2007, Angiogenesis: an organizing principle for drug discovery?, Nat. Rev., Drug Discov., 6, 273, 10.1038/nrd2115
Fukata, 2001, Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells, Trends Pharmacol. Sci., 22, 32, 10.1016/S0165-6147(00)01596-0
Fukumoto, 2007, Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors, Tohoku J. Exp. Med., 211, 309, 10.1620/tjem.211.309
Galaria, 2004, Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration, J. Surg. Res., 122, 173, 10.1016/j.jss.2004.05.012
Gerthoffer, 2005, Actin cytoskeletal dynamics in smooth muscle contraction, Can. J. Physiol. Pharm., 83, 851, 10.1139/y05-088
Guay, 1997, Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27, J. Cell. Sci., 110, 357, 10.1242/jcs.110.3.357
Guilluy, 2005, Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension, Br. J. Pharmacol., 146, 1010, 10.1038/sj.bjp.0706408
Haefliger, 1994, Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway, Invest. Ophthalmol. Vis. Sci., 35, 991
Hammes, 2005, Pericytes and the pathogenesis of diabetic retinopathy, Horm. Metab. Res., 37, 39, 10.1055/s-2005-861361
Harris, 1980, Silicone rubber substrata: a new wrinkle in the study of cell locomotion, Science, 208, 177, 10.1126/science.6987736
Hashimoto, 1999, Distribution of Rho-kinase in the bovine brain, Biochem. Biophys. Res. Commun., 263, 575, 10.1006/bbrc.1999.1409
Hattori, 2004, Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice, Circulation, 109, 2234, 10.1161/01.CIR.0000127939.16111.58
Hattori, 2004, Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice, Circ. Res., 94, 46, 10.1161/01.RES.0000107196.21335.2B
Hayashi, 2002, Neuronal nitric oxide has a role as a perfusion regulator and a synaptic modulator in cerebellum but not in neocortex during somatosensory stimulation—an animal PET study, Neurosci. Res., 44, 155, 10.1016/S0168-0102(02)00122-0
Healy, 1992, Density-dependent accumulation of basic fibroblast growth factor in the subendothelial matrix, Eur. J. Cell Biol., 59, 56
Healy, 1992, Preparation of fluorescent basic fibroblast growth factor: localization in living retinal microvascular endothelial cells, Exp. Eye Res., 55, 663, 10.1016/0014-4835(92)90171-N
Hellstrom, 1999, Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse, Development, 126, 3047, 10.1242/dev.126.14.3047
Hellstrom, 2001, Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis, J. Cell Biol., 153, 543, 10.1083/jcb.153.3.543
Herman, 1985, Microvascular pericytes contain muscle and nonmuscle actins, J. Cell Biol., 101, 43, 10.1083/jcb.101.1.43
Herman, 1988, In situ analysis of microvascular pericytes in hypertensive rat brains, Tissue Cell, 20, 1, 10.1016/0040-8166(88)90002-X
Herman, 1987, Characterization of microvascular cell cultures from normotensive and hypertensive rat brains: pericyte–endothelial cell interactions in vitro, Tissue Cell, 19, 197, 10.1016/0040-8166(87)90005-X
Higashi, 2003, Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system, Circ. Res., 93, 767, 10.1161/01.RES.0000096650.91688.28
Hilgers, 2005, Molecular aspects of arterial smooth muscle contraction: focus on Rho, Exp. Biol. Med. (Maywood), 230, 829, 10.1177/153537020523001107
Hiraga, 2006, Rho-kinase inhibition enhances axonal regeneration after peripheral nerve injury, J. Peripher. Nerv. Syst., 11, 217, 10.1111/j.1529-8027.2006.00091.x
Hirata, 1992, Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction, J. Biol. Chem., 267, 8719, 10.1016/S0021-9258(19)50337-4
Hirschi, 1996, Pericytes in the microvasculature, Cardiovasc. Res., 32, 687, 10.1016/S0008-6363(96)00063-6
Hirschi, 1997, Control of angiogenesis by the pericyte: molecular mechanisms and significance, EXS, 79, 419
Hirschi, 1997, Cell–cell interactions in vessel assembly: a model for the fundamentals of vascular remodelling, Transpl. Immunol., 5, 177, 10.1016/S0966-3274(97)80034-2
Hirschi, 1998, PDGF, TGF-beta, and heterotypic cell–cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate, J. Cell Biol., 141, 805, 10.1083/jcb.141.3.805
Hirst, 1982, Transmitted light microscopy of the unstained endothelial cell layer of excised human corneal tissue, Invest. Ophthalmol. Vis. Sci., 22, 811
Hoshijima, 1998, The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase, J. Biol. Chem., 273, 7725, 10.1074/jbc.273.13.7725
Hossmann, 1994, Viability thresholds and the penumbra of focal ischemia, Ann. Neurol., 36, 557, 10.1002/ana.410360404
Hungerford, 1999, Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall, J. Vasc. Res., 36, 2, 10.1159/000025622
Iadecola, 1995, Nitric oxide contributes to functional hyperemia in cerebellar cortex, Am. J. Physiol., 268, R1153
Iadecola, 1997, Local and propagated vascular responses evoked by focal synaptic activity in cerebellar cortex, J. Neurophysiol., 78, 651, 10.1152/jn.1997.78.2.651
Iadecola, 1997, Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene, J. Neurosci., 17, 9157, 10.1523/JNEUROSCI.17-23-09157.1997
Ingber, 2002, Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology, Circ. Res., 91, 877, 10.1161/01.RES.0000039537.73816.E5
Ishimaru, 2007, Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats, J. Cardiovasc. Pharmacol., 50, 187, 10.1097/FJC.0b013e318064f150
Ishizaki, 2000, Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases, Mol. Pharmacol., 57, 976
Ito, 2003, Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension, Circ. Res., 92, 1337, 10.1161/01.RES.0000079941.59846.D4
Ito, 2004, Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition, Hypertension, 43, 156, 10.1161/01.HYP.0000114602.82140.a4
Ito, 2005, Effects of hydroxyfasudil administered to the nucleus tractus solitarii on blood pressure and heart rate in spontaneously hypertensive rats, Clin. Exp. Hypertens., 27, 269, 10.1081/CEH-48876
Ito, 2004, Myosin phosphatase: structure, regulation and function, Mol. Cell. Biochem., 259, 197, 10.1023/B:MCBI.0000021373.14288.00
Johnson, 1992, TNF-alpha augments pulmonary vasoconstriction via the inhibition of nitrovasodilator activity, J. Appl. Physiol., 73, 2483, 10.1152/jappl.1992.73.6.2483
Jo, 2006, Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization, Am. J. Pathol., 168, 2036, 10.2353/ajpath.2006.050588
Just, 1994, Clostridium difficile toxin B acts on the GTP-binding protein Rho, J. Biol. Chem., 269, 10706, 10.1016/S0021-9258(17)34116-9
Kalman, 1999, Ras family GTPases control growth of astrocyte processes, Mol. Biol. Cell, 10, 1665, 10.1091/mbc.10.5.1665
Kamm, 1985, The function of myosin and myosin light chain kinase phosphorylation in smooth muscle, Annu. Rev. Pharmacol. Toxicol., 25, 593, 10.1146/annurev.pa.25.040185.003113
Kandabashi, 2000, Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta, Circulation, 101, 1319, 10.1161/01.CIR.101.11.1319
Kandabashi, 2003, Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm, Arterioscler. Thromb. Vasc. Biol., 23, 2209, 10.1161/01.ATV.0000104010.87348.26
Kawamura, 2002, Endothelin-induced changes in the physiology of retinal pericytes, Invest. Ophthalmol. Vis. Sci., 43, 882
Kawamura, 2003, ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina, J. Physiol., 551, 787, 10.1113/jphysiol.2003.047977
Kawamura, 2004, Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina, J. Physiol., 561, 671, 10.1113/jphysiol.2004.073098
Kawano, 1999, Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo, J. Cell Biol., 147, 1023, 10.1083/jcb.147.5.1023
Khosravi-Far, 1995, Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation, Mol. Cell. Biol., 15, 6443, 10.1128/MCB.15.11.6443
Kishi, 2005, Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure, Circulation, 111, 2741, 10.1161/CIRCULATIONAHA.104.510248
Kocher, 1989, Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1, In Vitro Cell Dev. Biol., 25, 424, 10.1007/BF02624627
Kolyada, 2003, Rho GTPase signaling modulates cell shape and contractile phenotype in an isoactin-specific manner, Am. J. Physiol., Cell Physiol., 285, C1116, 10.1152/ajpcell.00177.2003
Kondo, 2005, PKC/MAPK signaling suppression by retinal pericyte conditioned medium prevents retinal endothelial cell proliferation, J. Cell. Physiol., 203, 378, 10.1002/jcp.20237
Krogh, 1920
Kutcher, 2007, Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state, Am. J. Pathol., 171, 693, 10.2353/ajpath.2007.070102
Kuwabara, 1963, Retinal vascular patterns. VI. Mural cells of the retinal capillaries, Arch. Ophthalmol., 69, 492, 10.1001/archopht.1963.00960040498013
Larsen, 1997, Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle, Am. J. Physiol., 273, L930
Laun, 2003, Transforming growth factor-beta1 and major trauma: time-dependent association with hepatic and renal insufficiency, Shock, 19, 16, 10.1097/00024382-200301000-00004
Lauritzen, 2001, Relationship of spikes, synaptic activity, and local changes of cerebral blood flow, J. Cereb. Blood Flow Metab., 21, 1367, 10.1097/00004647-200112000-00001
Lee, 2004, Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature, Hypertension, 44, 796, 10.1161/01.HYP.0000148303.98066.ab
Lee, 2005, Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts, Am. J. Pathol., 166, 1861, 10.1016/S0002-9440(10)62495-9
Lehoux, 2006, Molecular mechanisms of the vascular responses to haemodynamic forces, J. Intern. Med., 259, 381, 10.1111/j.1365-2796.2006.01624.x
Liao, 2007, Rho kinase (ROCK) inhibitors, J. Cardiovasc. Pharmacol., 50, 17, 10.1097/FJC.0b013e318070d1bd
Lindahl, 1997, Pericyte loss and microaneurysm formation in PDGF-B-deficient mice, Science, 277, 242, 10.1126/science.277.5323.242
Lindblom, 2003, Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall, Genes Dev., 17, 1835, 10.1101/gad.266803
Liu, 1992, Role of nitric oxide and guanosine 3′,5′-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries, Br. J. Pharmacol., 107, 861, 10.1111/j.1476-5381.1992.tb14538.x
Lohn, 2005, Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation, Eur. J. Pharmacol., 507, 179, 10.1016/j.ejphar.2004.11.047
Loirand, 2006, Rho kinases in cardiovascular physiology and pathophysiology, Circ. Res., 98, 322, 10.1161/01.RES.0000201960.04223.3c
Louvet-Vallee, 2000, ERM proteins: from cellular architecture to cell signaling, Biol. Cell, 92, 305, 10.1016/S0248-4900(00)01078-9
Mallat, 2003, Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice, Circ. Res., 93, 884, 10.1161/01.RES.0000099062.55042.9A
Mammoto, 2008, Rho signaling and mechanical control of vascular development, Curr. Opin. Hematol., 15, 228, 10.1097/MOH.0b013e3282fa7445
Mancuso, 2006, Rapid vascular regrowth in tumors after reversal of VEGF inhibition, J. Clin. Invest., 116, 2610, 10.1172/JCI24612
Mandegar, 2004, Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension, Microvasc. Res., 68, 75, 10.1016/j.mvr.2004.06.001
Masumoto, 2002, Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina, Circulation, 105, 1545, 10.1161/hc1002.105938
Matsui, 1998, Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association, J. Cell Biol., 140, 647, 10.1083/jcb.140.3.647
Matsui, 1999, Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases, Curr. Biol., 9, 1259, 10.1016/S0960-9822(99)80508-9
Meyrick, 1980, Ultrastructural findings in lung biopsy material from children with congenital heart defects, Am. J. Pathol., 101, 527
Meyrick, 1981, Smooth muscle myosin in precursor and mature smooth muscle cells in normal pulmonary arteries and the effect of hypoxia, Exp. Lung Res., 2, 303, 10.3109/01902148109052325
Ming, 2002, Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells, Mol. Cell. Biol., 22, 8467, 10.1128/MCB.22.24.8467-8477.2002
Ming, 2004, Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction, Circulation, 110, 3708, 10.1161/01.CIR.0000142867.26182.32
Mohri, 2003, Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm, J. Am. Coll. Cardiol., 41, 15, 10.1016/S0735-1097(02)02632-3
Morikawa, 2002, Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors, Am. J. Pathol., 160, 985, 10.1016/S0002-9440(10)64920-6
Moriki, 2004, RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats, Hypertens. Res., 27, 263, 10.1291/hypres.27.263
Morishige, 2001, Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo, Arterioscler. Thromb. Vasc. Biol., 21, 548, 10.1161/01.ATV.21.4.548
Moriyama, 2004, The Rho-ROCK system as a new therapeutic target for preventing interstitial fibrosis, Drug News Perspect., 17, 29, 10.1358/dnp.2004.17.1.829023
Morrell, 2006, Therapeutic concepts for hypoxic pulmonary vasoconstriction involving ion regulation and the smooth muscle contractile apparatus, J. Mol. Cell. Cardiol., 40, 751, 10.1016/j.yjmcc.2006.03.431
Nagaoka, 2005, Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension, Am. J. Respir. Crit. Care Med., 171, 494, 10.1164/rccm.200405-637OC
Negoro, 1999, The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells, Biochem. Biophys. Res. Commun., 262, 211, 10.1006/bbrc.1999.1129
Newcomb, 1993, Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle, J. Cell. Physiol., 155, 385, 10.1002/jcp.1041550220
Nick, 2000, Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation, J. Immunol., 164, 2151, 10.4049/jimmunol.164.4.2151
Nohria, 2006, Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease, Circ. Res., 99, 1426, 10.1161/01.RES.0000251668.39526.c7
Noma, 2003, Smoking activates rho-kinase in smooth muscle cells of forearm vasculature in humans, Hypertension, 41, 1102, 10.1161/01.HYP.0000067062.92836.9E
Noma, 2006, Physiological role of ROCKs in the cardiovascular system, Am. J. Physiol., Cell Physiol., 290, C661, 10.1152/ajpcell.00459.2005
Nwariaku, 2003, Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability, J. Appl. Physiol., 95, 1889, 10.1152/japplphysiol.00225.2003
O'Kane, 2003, Distribution of Rho family GTPases in the adult rat hippocampus and cerebellum, Brain Res. Mol. Brain Res., 114, 1, 10.1016/S0169-328X(03)00121-9
Olenik, 1997, Gene expression of the small GTP-binding proteins RhoA, RhoB, Rac1, and Cdc42 in adult rat brain, Brain Res. Mol. Brain Res., 52, 263, 10.1016/S0169-328X(97)00270-2
Olson, 2008, Applications for ROCK kinase inhibition, Curr. Opin. Cell Biol., 20, 242, 10.1016/j.ceb.2008.01.002
Orlidge, 1987, Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells, J. Cell Biol., 105, 1455, 10.1083/jcb.105.3.1455
Pacaud, 2005, Rho proteins and vascular diseases, Arch. Mal. Coeur Vaiss., 98, 249
Pak, 2007, The effects of hypoxia on the cells of the pulmonary vasculature, Eur. Respir. J., 30, 364, 10.1183/09031936.00128706
Pannarale, 1996, Precapillary patterns and perivascular cells in the retinal microvasculature. A scanning electron microscope study, J. Anat., 188, 693
Papetti, 2002, Mechanisms of normal and tumor-derived angiogenesis, Am. J. Physiol., Cell Physiol., 282, C947, 10.1152/ajpcell.00389.2001
Papetti, 2003, FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways, Invest. Ophthalmol. Vis. Sci., 44, 4994, 10.1167/iovs.03-0291
Peppiatt, 2006, Bidirectional control of CNS capillary diameter by pericytes, Nature, 443, 700, 10.1038/nature05193
Pfister, 2008, Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy, Diabetes, 57, 2495, 10.2337/db08-0325
Pietras, 2005, A multitargeted, metronomic, and maximum-tolerated dose “chemo-switch” regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer, J. Clin. Oncol., 23, 939, 10.1200/JCO.2005.07.093
Pittet, 2001, TGF-beta is a critical mediator of acute lung injury, J. Clin. Invest., 107, 1537, 10.1172/JCI11963
Qiu, 1995, A role for Rho in Ras transformation, Proc. Natl. Acad. Sci. U. S. A., 92, 11781, 10.1073/pnas.92.25.11781
Qvigstad, 2005, Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart, Circ. Res., 97, 268, 10.1161/01.RES.0000176970.22603.8d
Rattner, 2006, Macular degeneration: recent advances and therapeutic opportunities, Nat. Rev., Neurosci., 7, 860, 10.1038/nrn2007
Riddick, 2008, Targeting by myosin phosphatase-RhoA interacting protein mediates RhoA/ROCK regulation of myosin phosphatase, J. Cell. Biochem., 103, 1158, 10.1002/jcb.21488
Rikitake, 2005, Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells, Circulation, 111, 3261, 10.1161/CIRCULATIONAHA.105.534024
Rikitake, 2005, Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection, Stroke, 36, 2251, 10.1161/01.STR.0000181077.84981.11
Rouget, 1873, Mémoire sur le développement, la structure et les proprietés physiologiques des capillaires sanguins et lymphatiques, Arch. Physiol. Norm et Path, 603
Rucker, 2000, Vasomotion in critically perfused muscle protects adjacent tissues from capillary perfusion failure, Am. J. Physiol, Heart Circ. Physiol., 279, H550, 10.1152/ajpheart.2000.279.2.H550
Sagara, 2007, Pressor response induced by central angiotensin II is mediated by activation of Rho/Rho-kinase pathway via AT1 receptors, J. Hypertens., 25, 399, 10.1097/HJH.0b013e328010b87f
Sakagami, 2001, Nitric oxide/cGMP-induced inhibition of calcium and chloride currents in retinal pericytes, Microvasc. Res., 62, 196, 10.1006/mvre.2001.2343
Sato, 2000, Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm, Circ. Res., 87, 195, 10.1161/01.RES.87.3.195
Sato, 1989, Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture, J. Cell Biol., 109, 309, 10.1083/jcb.109.1.309
Sato, 1990, Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system, J. Cell Biol., 111, 757, 10.1083/jcb.111.2.757
Sauzeau, 2003, Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery, Circ. Res., 93, 630, 10.1161/01.RES.0000093220.90027.D9
Savoia, 2006, Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase, J. Hypertens., 24, 2417, 10.1097/01.hjh.0000251902.85675.7e
Seko, 2003, Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle, Circ. Res., 92, 411, 10.1161/01.RES.0000059987.90200.44
Shaheen, 2001, Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms, Cancer Res., 61, 1464
Sheppard, 2005, Integrin-mediated activation of latent transforming growth factor beta, Cancer Metastasis Rev., 24, 395, 10.1007/s10555-005-5131-6
Shibuya, 1990, Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage, Acta Neurochir. (Wien), 107, 11, 10.1007/BF01402606
Shibuya, 1992, Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial, J. Neurosurg., 76, 571, 10.3171/jns.1992.76.4.0571
Shih, 2003, Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo, Proc. Natl. Acad. Sci. U. S. A., 100, 15859, 10.1073/pnas.2136855100
Shimokawa, 2005, Rho-kinase is an important therapeutic target in cardiovascular medicine, Arterioscler. Thromb. Vasc. Biol., 25, 1767, 10.1161/01.ATV.0000176193.83629.c8
Sime, 1997, Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung, J. Clin. Invest., 100, 768, 10.1172/JCI119590
Somlyo, 2003, Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase, Physiol. Rev., 83, 1325, 10.1152/physrev.00023.2003
Song, 2005, PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival, Nat. Cell Biol., 7, 870, 10.1038/ncb1288
Sumi, 1999, Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2, J. Cell Biol., 147, 1519, 10.1083/jcb.147.7.1519
Sumi, 2001, Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase, J. Biol. Chem., 276, 670, 10.1074/jbc.M007074200
Surks, 2003, Myosin phosphatase-Rho interacting protein. A new member of the myosin phosphatase complex that directly binds RhoA, J. Biol. Chem., 278, 51484, 10.1074/jbc.M305622200
Surks, 2005, M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells, J. Biol. Chem., 280, 42543, 10.1074/jbc.M506863200
Takayasu, 1986, The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs, J. Neurosurg., 65, 80, 10.3171/jns.1986.65.1.0080
Takemoto, 2002, Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase, Circulation, 106, 57, 10.1161/01.CIR.0000020682.73694.AB
Topper, 1997, Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium, Proc. Natl. Acad. Sci. U. S. A., 94, 9314, 10.1073/pnas.94.17.9314
Topper, 1998, CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells, Proc. Natl. Acad. Sci. U. S. A., 95, 9506, 10.1073/pnas.95.16.9506
Touyz, 2001, Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar–Kyoto rats and spontaneously hypertensive rats, J. Hypertens., 19, 553, 10.1097/00004872-200103001-00006
Tsai, 2006, Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction, Pflugers Arch., 453, 223, 10.1007/s00424-006-0133-y
Uehata, 1997, Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension, Nature, 389, 990, 10.1038/40187
Vinals, 2001, Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling, Mol. Cell. Biol., 21, 7218, 10.1128/MCB.21.21.7218-7230.2001
von Tell, 2006, Pericytes and vascular stability, Exp. Cell Res., 312, 623, 10.1016/j.yexcr.2005.10.019
Wang, 2004, P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression, Shock, 21, 170, 10.1097/01.shk.0000110623.20647.aa
Watanabe, 2005, Activation of Rho-associated kinase during augmented contraction of the basilar artery to serotonin after subarachnoid hemorrhage, Am. J. Physiol, Heart Circ. Physiol., 288, H2653, 10.1152/ajpheart.00923.2004
Wilkinson-Berka, 2004, Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy, Am. J. Pathol., 164, 1263, 10.1016/S0002-9440(10)63214-2
Wolfrum, 2004, Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection, Arterioscler. Thromb. Vasc. Biol., 24, 1842, 10.1161/01.ATV.0000142813.33538.82
Woodsome, 2006, Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells, J. Cell. Sci., 119, 1769, 10.1242/jcs.02805
Wu, 2001, Dopamine activates ATP-sensitive K+ currents in rat retinal pericytes, Vis. Neurosci., 18, 935, 10.1017/S0952523801186104
Wu, 2003, Cholinergic regulation of pericyte-containing retinal microvessels, Am. J. Physiol, Heart Circ. Physiol., 284, H2083, 10.1152/ajpheart.01007.2002
Yamagishi, 2005, Pericyte biology and diseases, Int. J. Tissue React., 27, 125
Yang, 1999, Nitric oxide is the predominant mediator of cerebellar hyperemia during somatosensory activation in rats, Am. J. Physiol., 277, R1760
Yang, 2003, Attenuation of activity-induced increases in cerebellar blood flow in mice lacking neuronal nitric oxide synthase, Am. J. Physiol, Heart Circ. Physiol., 285, H298, 10.1152/ajpheart.00043.2003
Yang, 1998, Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization, Nature, 393, 809, 10.1038/31735
Yonemura, 2002, Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo, J. Cell. Sci., 115, 2569, 10.1242/jcs.115.12.2569